Trade

with

DepoMed Inc
(NASDAQ: DEPO)
AdChoices
15.10
-0.12
-0.79%
After Hours :
15.10
0.00
0.00%

Open

15.21

Previous Close

15.22

Volume (Avg)

718.90k (1.18M)

Day's Range

15.03-15.25

52Wk Range

7.09-15.70

Market Cap.

890.01M

Dividend Rate ( Yield )

-

Beta

1.54

Shares Outstanding

58.48M

P/E Ratio (EPS)

11.44 (1.33)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 134.21M

    • Net Income

    • 43.31M

    • Market Cap.

    • 890.01M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 35.53

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.54

    • Forward P/E

    • 50.25

    • Price/Sales

    • 4.04

    • Price/Book Value

    • 4.92

    • Price/Cash flow

    • -19.65

      • EBITDA

      • 16.14M

      • Return on Capital %

      • 26.67

      • Return on Equity %

      • 60.25

      • Return on Assets %

      • 26.67

      • Book Value/Share

      • 3.07

      • Shares Outstanding

      • 58.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 13.50

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 0.07

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 126.10

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • 2,566.50

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 30.96

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 94.47

            • 64.72

            • Pre-Tax Margin

            • 27.18

            • 13.77

            • Net Profit Margin

            • 35.53

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 93.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -1.90

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 3.90

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.33

              • Current Ratio

              • 2.70

              • 1.52

              • Quick Ratio

              • 2.38

              • 0.87

              • Interest Coverage

              • 4.60

              • 6.77

              • Leverage Ratio

              • 2.56

              • 1.91

              • Book Value/Share

              • 3.07

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 11.17

                • 65.79

                • P/E Ratio 5-Year High

                • 11.67

                • 237.47

                • P/E Ratio 5-Year Low

                • 1.74

                • 19.71

                • Price/Sales Ratio

                • 3.97

                • 3.69

                • Price/Book Value

                • 4.84

                • 3.46

                • Price/Cash Flow Ratio

                • -19.65

                • 22.12

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 60.25

                    (9.50)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 26.67

                    (6.20)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 69.10

                    (10.90)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 256.49k

                  • 27.79k

                  • Inventory Turnover

                  • 1.64

                  • 1.80

                  • Asset Turnover

                  • 0.75

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  9.32M
                  Operating Margin
                  6.94
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -19.65
                  Ownership

                  Institutional Ownership

                  88.62%

                  Top 10 Institutions

                  54.23%

                  Mutual Fund Ownership

                  37.67%

                  Float

                  99.60%

                  5% / Insider Ownership

                  4.14%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • PowerShares Dynamic Pharmaceuticals Port

                  •  

                    2,670,962

                  • 0.00

                  • 4.58

                  • SPDR® S&P Pharmaceuticals ETF

                  •  

                    1,807,312

                  • 0.00

                  • 3.10

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    1,185,516

                  • 0.20

                  • 2.03

                  • Vanguard Total Stock Mkt Idx

                  •  

                    941,657

                  • 0.49

                  • 1.61

                  • iShares Russell 2000 (AU)

                  •  

                    866,061

                  • -1.46

                  • 1.48

                  • iShares Nasdaq Biotechnology

                  •  

                    756,537

                  • -0.47

                  • 1.30

                  • TIAA-CREF Small-Cap Equity

                  •  

                    591,152

                  • 30.85

                  • 1.01

                  • Vanguard Extended Market Index Fund

                  •  

                    552,376

                  • -14.76

                  • 0.94

                  • iShares US Pharmaceuticals

                  •  

                    542,985

                  • 0.00

                  • 0.93

                  • Vanguard Strategic Equity Fund

                  •  

                    524,200

                  • 37.87

                  • 0.90

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • SENVEST INTERNATIONAL LLC

                  •  

                    4,251,330

                  • -4.90%

                  • 7.28

                  • Ingalls & Snyder LLC

                  •  

                    3,977,234

                  • -1.12%

                  • 6.81

                  • State Street Corp

                  •  

                    3,221,591

                  • +70.87%

                  • 5.51

                  • Invesco PowerShares Capital Mgmt LLC

                  •  

                    2,845,855

                  • -3.05%

                  • 4.87

                  • Vanguard Group, Inc.

                  •  

                    2,701,716

                  • +36.97%

                  • 4.62

                  • BlackRock Fund Advisors

                  •  

                    2,621,621

                  • -2.85%

                  • 4.49

                  • Broadfin Capital, LLC

                  •  

                    2,471,692

                  • -22.54%

                  • 4.23

                  • Deltec Asset Management LLC

                  •  

                    2,299,109

                  • -9.33%

                  • 3.93

                  • Millennium Management LLC

                  •  

                    1,060,671

                  • -53.46%

                  • 1.82

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Slow Growth

                  Style

                  Small Growth

                  Depomed, Inc., was incorporated in the State of California on August 7, 1995. The Company is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system. The Products that compr...moreise its specialty pharmaceutical business are Gralise®, Zipsor® (diclofenac potassium) liquid filled capsules, its non-steriodal anti-inflammatory drug for the treatment of mild to moderate acute pain, CAMBIA®, its non-steriodal anti-inflammatory drug for the acute treatment of migraine attacks, and Lazanda® nasal spray, its product for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. The Company’s operation and business are subjec...moret to a number of other laws and regulations, including those relating to the workplace, privacy, laboratory practices and the purchase, storage, movement, import and export and use and disposal of hazardous or potentially hazardous substances as well as controlled substances.lessless

                  Key People

                  James A. Schoeneck

                  CEO/Director/President

                  Peter D. Staple

                  Chairman of the Board/Director

                  August J. Moretti

                  CFO/Senior VP

                  Mr. Jeff Coon

                  Vice President, Divisional

                  Mr. Steve Greco

                  Vice President, Divisional

                  • DepoMed Inc

                  • 7999 Gateway Boulevard

                  • Newark, CA 94560

                  • USA.Map

                  • Phone: +1 510 744-8000

                  • Fax: +1 650 744-8001

                  • depomedinc.com

                  Incorporated

                  1995

                  Employees

                  308

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: